REPLIGEN CORP - 8-K Filing

Repligen completed acquisition of BioLife Solutions on October 6, 2026. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $RGEN

Read the full article at SEC EDGAR

More Regulatory news